List of works by Pier Francesco Ferrucci

ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma.

scientific article

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

scientific article published on 01 August 1999

Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.

scientific article published on June 2008

Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.

scientific article published on 12 April 2017

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

scientific article

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab

scientific article published on 01 February 2018

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

scientific article

Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma.

scientific article published in August 2017

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

article

Cerebrospinal fluid diffusion of Zevalin after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement.

scientific article

Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers

scientific article

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

scientific article

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

scientific article (publication date: 2 July 2015)

Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.

scientific article published on June 1998

Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study. ⬇️

scientific article published on 2 March 2018

Course of Sars-CoV2 infection in patients with cancer treated with anti-PD-1: a case presentation and review of the literature

scientific article published on 30 October 2020

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer

scientific article published on 12 March 2000

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience

scientific article published on 3 March 2016

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

scientific article published on 06 June 2019

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

scientific article published in June 2015

Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected]

scientific article published on 01 June 2009

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

scientific article published on 01 October 2019

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

scientific article

Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin's lymphoma.

scientific article published on 13 March 2008

Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach

scientific article

Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma

scientific article published on 01 July 2000

Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy.

scientific article published on January 2000

Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma

scientific article published on 11 March 2018

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

scientific article published on 28 September 2019

Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).

scientific article published on 16 June 2017

HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future

scientific article

Health-related quality of life results from the phase III CheckMate 067 study.

scientific article published on 22 June 2017

Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.

scientific article published on 26 March 2014

High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.

scientific article published in November 2007

High-dose radioimmunotherapy with 90Y-ibritumomab tiuxetan: comparative dosimetric study for tailored treatment

scientific article published in November 2007

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin

scientific article

In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes

scientific article published in July 1998

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

scientific article

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

scientific article

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

scientific article published on 11 March 2014

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in <i>BRAF</i>-mutant melanoma

scientific article published on 01 December 2020

Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer

scientific article

Maspin expression and melanoma progression: a matter of sub-cellular localization.

scientific article

Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia.

scientific article

Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.

scientific article published on 12 November 2016

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

scientific article published on 22 October 2018

Oncophage: step to the future for vaccine therapy in melanoma

scientific article published in December 2008

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.

scientific article published on August 1997

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

scientific article published on 11 September 2017

PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.

scientific article published on August 1994

Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival

scientific article published on 25 September 2018

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

scientific article published on 27 July 2015

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

scientific article published on 15 September 2017

Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?

scientific article published on 8 December 2006

Prognostic significance of hematological profiles in melanoma patients

scientific article published on 2 June 2016

Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.

scientific article

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP).

scientific article published on 7 November 2013

Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome

scientific article published on 28 December 2018

Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis

scientific article published on 01 August 2019

ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma

scientific article published on 13 November 2020

Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.

scientific article published on 29 March 2017

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

article

Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy

scientific article

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers

scientific article published in July 2001

The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.

scientific article published on 30 July 2011

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.

scientific article published in August 2018

Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device

scientific article published on 01 July 1999

Paulina is supported by:

About Paulina

Help